Follow CGSP on Social Media

Listen to the CGSP Podcast

COVID Wave Drives Chinese Consumers to Indian Generics

TRANSLATION: Thousands of dollars for Indian-made generic COVID medications sold out? Be careful!

As the BF7 Omicron variant pushes China’s public health care system to its limits, the country is running out of antiviral medications like Pfizer’s Paxlovid.

These shortages seem to be driving people to the black market, with consumers competing to order generic versions of the drug, many from India, that haven’t been approved in China.

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

What is The China-Global South Project?


The China-Global South Project is passionately independent, non-partisan and does not advocate for any country, company or culture.


A carefully curated selection of the day’s most important China-Global South stories. Updated 24 hours a day by human editors. No bots, no algorithms.


Diverse, often unconventional insights from scholars, analysts, journalists and a variety of stakeholders in the China-Global South discourse.


A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.